Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Michael A. Pulsipher, Kwang W. Ahn, Nancy J. Bunin, Nahal Lalefar, Eric Anderson, Allyson Flower, Mitchell S. Cairo, Julie-An Talano, Sonali Chaudhury, Carrie L. Kitko, Jamie L. Duke, Dimitrios Monos, Wing Leung, Christopher C. Dvorak, Hisham Abdel-Azim

Blood (2022) 140 (24): 2556–2572.

https://doi.org/10.1182/blood.2022015959

Published: 2022

Includes: Supplemental data

Journal Articles

Is autologous transplant in relapsed DLBCL patients achieving only a PET + PR appropriate in the CAR T-cell era?

Nirav N. Shah, Kwang W. Ahn, Carlos Litovich, Yizeng He, Craig Sauter, Timothy S. Fenske, Mehdi Hamadani

Blood (2021) 137 (10): 1416–1423.

https://doi.org/10.1182/blood.2020007939

Published: 2021

Includes: Supplemental data

Journal Articles

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Blood (2016) 127 (7): 938–947.

https://doi.org/10.1182/blood-2015-09-671834

Published: 2016

Includes: Supplemental data

Journal Articles

Meta-Analysis of Pharmacotherapy Vs. Observation for Management of Smoldering Multiple Myeloma

Jayanthi Vijayakumar, MBBS, Jeffrey Jackson, MD MPH, Kwang W Ahn, PhD, Parameswaran N. Hari, MD MRCP, MS

Blood (2014) 124 (21): 4771.

https://doi.org/10.1182/blood.V124.21.4771.4771

Published: 2014

Journal Articles

FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Abhinav Deol, MD, Salyka Sengsayadeth, MD, Madan Jagasia, MBBS, MS, Kwang W Ahn, PhD, Hailin Wang, MPH, Brenda M. Sandmaier, MD, Steven M. Devine, MD, Marcos de Lima, MD, Daniel J. Weisdorf, MD, Wael Saber, MD MS

Blood (2014) 124 (21): 322.

https://doi.org/10.1182/blood.V124.21.322.322

Published: 2014

Journal Articles

Impact of Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Grade-III Follicular (FL-III) and Diffuse Large B-Cell Lymphomas (DLBCL): A Cibmtr Analysis

Mehdi Hamadani, MD, Wael Saber, MD, MS, Jeanette Carreras, MPH, Kwang W. Ahn, PhD, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Hillard M. Lazarus, MD

Blood (2012) 120 (21): 473.

https://doi.org/10.1182/blood.V120.21.473.473

Published: 2012

Journal Articles

Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Edward A. Copelan, MD, Betty K. Hamilton, MD, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Belinda Avalos, MD, Brian J. Bolwell, MD, Robert Peter Gale, MD, PhD, DSc, Jorge E. Cortes, MD, Matt Kalaycio, MD, Richard T. Maziarz, MD, Wael Saber, MD, MS

Blood (2012) 120 (21): 217.

https://doi.org/10.1182/blood.V120.21.217.217

Published: 2012

Journal Articles

Effect of Graft Source and Transplant Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Mantle Cell Lymphoma (MCL): A Cibmtr Analysis

Mehdi Hamadani, MD, Wael Saber, MD, MS, Jeanette Carreras, MPH, Kwang W Ahn, PhD, Ginna G Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Hillard M Lazarus, MD

Blood (2012) 120 (21): 815.

https://doi.org/10.1182/blood.V120.21.815.815

Published: 2012

Journal Articles

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Vikas Gupta, MD, FRCP, FRCPath, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Zhenhuan Hu, MPH, Parameswaran Hari, MBBS, MD, MRCP, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Matt Kalaycio, MD, Wael Saber, MD, MS

Blood (2012) 120 (21): 432.

https://doi.org/10.1182/blood.V120.21.432.432

Published: 2012

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Effect of Race on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

Michael J Eckrich, MD, MPH, Kwang W Ahn, PhD, Zhiwei Wang, MS, H. Joachim Deeg, MD, Mary M. Horowitz, MD, Mary Eapen, MBBS

Blood (2011) 118 (21): 1020.

https://doi.org/10.1182/blood.V118.21.1020.1020

Published: 2011

Journal Articles

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Claudio Brunstein, MD, Mary Eapen, MBBS, Kwang w Ahn, PhD, Frederick R. Appelbaum, MD, Karen K Ballen, MD, Richard Champlin, Fangyu Kan, MS, Mary J. Laughlin, MD, Robert J Soiffer, MD, Daniel J. Weisdorf, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD, MS, John E. Wagner, MD

Blood (2010) 116 (21): 908.

https://doi.org/10.1182/blood.V116.21.908.908

Published: 2010

NARROW

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Is autologous transplant in relapsed DLBCL patients achieving only a PET + PR appropriate in the CAR T-cell era?

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Meta-Analysis of Pharmacotherapy Vs. Observation for Management of Smoldering Multiple Myeloma

FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Impact of Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Grade-III Follicular (FL-III) and Diffuse Large B-Cell Lymphomas (DLBCL): A Cibmtr Analysis

Lower Transplant-Related Mortality and Improved Survival for Patients with AML in First CR Receiving BuCy Compared to Cy/TBI As Myeloablative Preparation for Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Effect of Graft Source and Transplant Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Mantle Cell Lymphoma (MCL): A Cibmtr Analysis

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Effect of Race on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only